Company CEO to Co-Chair Symposium being held on April 11th in NYC

NEW YORK and CLEVELAND, April 05, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases, is pleased to announce a Gene Therapy for Rare Diseases Symposium with the New York Academy of Sciences (NYAS) and the Biochemical Pharmacology Discussion Group in New York City on April 11th, 2017.

“We are pleased to co-host this unique gene therapy symposium that highlights the importance of outcome measurements in gene therapy trial design, preclinical strategies, new clinical redosing paradigms and combination approaches for treating rare diseases,” stated Timothy J. Miller, PhD, President & CEO of Abeona Therapeutics.